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Abstract 
Acute myocardial infarction is a common cause for the significant reduction in delivery of 
nutrients and oxygen to cardiomyocytes, and with prolonged nutritional absence 
subsequently propagates chronic heart failure following cardiomyocyte cell death. 
Biomaterials research retains particular interest to redress chronic heart failure by 
emphasizing the regeneration of lost functional cardiac tissue via implantation of cardiac 
stem cells, specifically cardiosphere-derived stem cells (CDCs). While previous research 
has attempted to elucidate the capacity of novel thermosensitive polymeric hydrogels to 
sustain CDC survival in the construct, the physical properties of these gels are not well 
understood. Thus, this study sought to develop and characterize the physical properties of 
a thermo- and pH-sensitive hydrogel that would be forwarded towards studying 
encapsulated CDC survival. This gel was characterized by composition by nuclear magnetic 
resonance and fourier transform infrared spectroscopy, lower critical solution temperature 
by differential scanning calorimetry, elastic modulus by uniaxial tensile testing, 
biodegradability in water, and catheter injectability. A series of pH- and thermal responsive 
hydrogels were developed by free radical polymerization of n(isopropylacrylamide), 
propylacrylic acid, 2-hydroxyethyl methacrylate-co-trimethylene carbonate.  
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1. Introduction: 
1.1 Background 
Cardiovascular disease is the leading cause of death in the U.S., accounting for 
approximately one in four U.S. deaths each year and affecting 83.6 million U.S.  adults each 
year [1,2]. Furthermore, cardiovascular disease is projected to affect 40.8% of the U.S. 
population by 2030[3]. Of the conditions associated with cardiovascular disease (CVD), 
acute myocardial infarction (MI) is propagated through regional blockage of coronary 
arteries and impaired supply of oxygen and nutrition to areas of heart, leading to the 
failure and loss of heart cells that uphold normal heart functionality (Fig. 1). These lost 
cells cannot be regenerated by the body spontaneously and subsequently hinder normal 
cardiac function, resulting in death of heart tissue, and eventually heart failure [4]. While 
interventional procedures such as balloon angioplasty and stent placement seek to reduce 
the myocardial stresses coinciding with and onset by MI by restoring normal blood flow, 
they are deficient in restoring cardiac function to 
infarcted areas of the heart [5].  
 
 
Stem cell therapy is a promising method to cure 
MI through delivery of stem cells into the heart in 
order to regenerate lost myocardium. Delivered 
stem cells are recognized for their potential for 
full recovery of heart function, of which 
cardiosphere-derived stem cells (CDCs) are of particular interest for their capacity to 
Figure 1: Anatomy of myocardial 
infarction.  
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differentiate into new myocardium and endothelium - both in vivo and in vitro - and retain 
a high proliferation rate [6]. Unfortunately, current stem cell therapies, including direct 
injection of CDCs, experience low cell retention and survival resultant from the lack of 
matrix anchorage sites and harsh microenvironment of the infarcted area [7]. Encapsulated 
CDC delivery has been accomplished through open-heart surgery, but this method is time-
sensitive and leaves the patient prone to post-operative infection. Thus, a means to 
improve efficacy of stem cell therapy that would counteract low cell retention and 
engraftment, and provide a stable environment for stem cells to differentiate and 
reestablish lost heart tissue applying minimally-invasive methods is proposed to 
circumvent associated risks. 
 
 
1.2 Hydrogels 
 
Hydrogels are unique delivery vehicles for tissue engineering and regenerative medicine. 
Hydrogels are water-swollen, cross-linked networked polymeric structures held together 
through hydrogen bonding and van der Waal inter-chain interactions [8]. Hydrogels are 
exceptional candidates for application in stem cell therapy due to their capacity to establish 
a stable biochemical and biomechanical environment, like that of typical cardiac conditions, 
while sustaining stem engraftments [9]. Specifically, thermoresponsive hydrogels are 
particularly effective for their solidification upon injection that would allow cells to 
physically bind and establish a matrix for stem cell adhesion [10]. The family of n-
isopropylacrylamide-based (NIPAAm) thermoresponsive hydrogels have gained significant 
attention for increased cell retention consequent from fast gelation in situ at near core body 
temperature, improved cell survival and capacity to stimulate stem cell differentiation by 
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providing a suitable matrix. As these gels are thermally sensitive, the hydrogels may be 
delivered through minimally-invasive catheter application. These NIPAAm hydrogels are 
not readily applicable to stem cell therapy. Previously developed gels cannot be applied in 
catheter based percutaneous coronary intervention delivery because they are thermal-
sensitive only and would solidify prematurely within the near-body temperature (37oC) 
catheter, blocking any additional flow. Thus, a critical aim of this project addresses this 
situation by adjusting a pH sensitivity component to the polymer such that it would 
respond to the infarcted heart’s environmental pH of 6.5-6.8 [11]. This would allow 
continued flow of the hydrogel within the catheter but allow for rapid gelation in the 
afflicted region. Thus, modifications to the NIPAAm polymer must retain particular thermal 
and mechanical properties while negotiating pH-sensitivity in order to effectively 
accommodate the shortcomings of thermal sensitive hydrogels. 
Poly(n-isopropylacrylamide) (PNIPAAm) is a thermoresponsive hydrogel that exhibits a 
lower critical solution temperature at 32oC.  PNIPAAm thus forms a hydrogel at 
temperatures greater than 32oC yet stays in solution at temperatures lower than 32oC, 
within proximity of core body temperature [12].  
Propylacrylic acid (PAA) is a monomer characterized by an ionizable carboxyl group that 
lends PAA its pH-sensitivity [13]. Previous research indicates that a PAA-based hydrogel is 
able to maintain a solution state at pH 7.4 at body temperature and at lower pH at 5oC, but 
showed rapid gelation at low pH and at nominal body temperature [9]. This indicates an 
ideal candidate for minimally-invasive delivery of the hydrogel and rapid gelation on MI 
sites. 
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Hydroxyethyl methacrylate-poly(trimethylene carbonate) (HEMA-PTMC) is a 
biocompatible polymer that may adjust the mechanical properties of the hydrogel to 
achieve characteristics ideal for cell survival based upon varying molar ratios of NIPAAm 
and HEMA-PTMC [14]. Such characteristics may be adjusted to match mechanical 
properties similar to that of the heart, such as elasticity and dynamic motion. 
The objective of this project is to further develop and characterize hydrogel copolymer of 
various monomer ratios of NIPAAm, PAA, and HEMA-PTMC suitable for cardiosphere-
derived stem cell delivery. These hydrogels should retain tunable thermal, mechanical, and 
pH-sensitive properties that enable the gel to function in cardiac microenvironments, yet 
display a degree of degradability, injectability, and biocompatibility. 
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2. Materials and Methods 
2.1 Materials 
N-isopropylacrylamide and 2-hydroxyethyl methacrylate (HEMA) were purchased from 
VWR. NIPAAm was recrystallized three times with hexane. HEMA was purified by passing 
the HEMA through an inhibitor remover-packed column. Trimethylene carbonate (TMC) 
was purchased from Boehringer Ingelheim and was used without purification. Diethyl 
propylmalonate and diethylamine were purchased from Alfa Aesar and were used without 
purification. Formalin solution was purchased from Fischer Scientific and used without 
purification. Benzoyl peroxide (BPO) and other relevant solvents were used as received 
from VWR.  
 
2.2 Synthesis of Propylacrylic Acid  
Propylacrylic acid was synthesized following methods adopted from Ferritto and Tirrell 
[16] (Fig. 2). 25 g diethyl propylmalonate was used without purification and was stirred in 
175 mL 1 M KOH 95% ethanol solution for 18 hours. The mixture was condensed by rotary 
evaporator at 0oC and dissolved in a minimal amount of deionized water. The solution was 
acidified with 1 M hydrochloric acid to adjust to a pH of 2. The crude product was extracted 
with three times with 200 mL ethyl ether, dried by magnesium sulfate overnight, and 
filtered. Excess ether was removed by rotary evaporator. The structure of 2-
carboethoxypentanoic acid was confirmed by 1H-NMR. The oily product was reacted with 
12.8 mL diethylamine at -5oC and allowed to homogenize. 12.3 mL formalin solution was 
slowly added by addition funnel and allowed to stir for 24 hours. The mixture was then 
allowed to reflux for 8 hours at 60oC. The mixture was cooled to 0oC and concentrated 
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sulfuric acid was added until violent reaction ceased. The crude product was extracted with 
three times with 200 mL ethyl ether, dried by magnesium sulfate overnight, and filtered. 
The structure of the crude ethyl 2-propylacrylate was confirmed by 1H-NMR. The crude 
product was hydrolyzed by 1 M KOH and refluxed for 20 hours. The solution was acidified 
to adjust the product to pH 2. A yellow oil was separated and extracted with 200 mL ethyl 
ether diethyl ether three times, dried by magnesium sulfate overnight, and filtered. Excess 
ether was removed by rotary evaporator. 
 
Figure 2: Synthesis reaction schematic of propylacrylic acid 
 
2.3 Synthesis of hydroxyethyl methacrylate-poly(trimethylene carbonate)   
Hydroxyethyl methacrylate-poly(trimethylene carbonate) (HEMA-PTMC) was synthesized 
by reacting HEMA with TMC with a molar ratio of 1 to 2 respectively at 110oC for 1 hour 
with stannous octoate catalyst (Fig. 3) [9,10]. The crude product was dissolved in 
tetrahydrofuran (THF) and precipitated in 0oC deionized water. The mixture was 
centrifuged and the supernatant was poured off. The precipitate was re-dissolved in ethyl 
acetate and dried by magnesium sulfate. The product was condensed by rotary evaporator.  
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Figure 3: Synthesis reaction schematic of HEMA-PTMC 
 
2.4 Synthesis of poly(NIPAAm-co-PAA-co-HEMA-PTMC) 
NIPAAm, PAA, and HEMA-PTMC were reacted in varying molar ratios (Table 1) by free 
radical polymerization (Fig. 4) to obtain hydrogels with varying pH and mechanical 
properties. The reactants were dissolved in dioxane at 25oC, and the reaction flask was 
flushed with nitrogen gas for 15 minutes. The initiator benzoyl peroxide (BPO) was added 
and the reaction was maintained at 70oC for 20 hours. The solution was precipitated into 
hexane to obtain a white solid. The mixture was filtered and dissolved in tetrahydrofuran 
(THF). The crude product was then precipitated and by purified by THF and diethyl ether 
two times, then freeze-dried overnight.  
 
 
Figure 4: Synthesis reaction schematic of final product 
 
2 
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Table 1: Monomer molar feed ratio (%) (NIPAAm/PAA/HEMA-PTMC) 
Hydrogel Feed Ratio 
Gel 1 84/8/8 
Gel 2 83/12/5 
Gel 3 78/12/10 
 
2.5 Hydrogel Characterization 
20 % wt. hydrogel solution was prepared by dissolving dried copolymer in Dulbecco's 
phosphate-buffered saline (DPBS) at 0oC. Sodium hydroxide was used to adjust the pH of 
the dissolved hydrogel samples for differential scanning calorimetry and catheter 
injectability tests to pH 6.5 and 7.4. The pH of the hydrogel solutions were not adjusted for 
all other analyses. Composition of the hydrogels and functional groups were determined by 
nuclear magnetic resonance and fourier transform infrared spectroscopy. 
2.5.1 Hydrogel Water Degradation  
200 μL of 20 wt. % hydrogel solution was added to a 1.5 mL Eppendorf tube and allowed to 
gelate in a 37°C water bath for 24 h. The supernatant was discarded and replaced with 1 
mL of 37oC DPBS and the pellets were allowed to incubate at 37oC. Hydrogel water 
degradation was conducted over an eight week time period with samples collected at 
intervals in weeks 0, 1, 2, 3, 4, 6, 8. The hydrogel was freeze-dried at each time point and 
the remaining gel pellet was weighed in the interval progression, and the content loss was 
used to report weight remaining. The weight remaining was used to quantify the 
degradation of the hydrogels. 
2.5.2 Stretchability 
Hydrogel samples were allowed to solidify at 37oC for 1 hour to form solid pellet. The 
measured sample was sectioned to obtain a sample of 3.5 mm width, stretched in 37oC 
water bath, and its final length was observed.  
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2.5.3 Tensile Test 
Elastic modulus of the hydrogels was determined via tensile testing. Hydrogel samples 
were incubated at 37oC for 1 hour to form solid pellet and then sectioned into 4 samples 
each approximately 3.5 mm width and 20 mm length. The tensile test was conducted in a 
37oC water bath. A cross-head speed of 50 mm/min was used.  
2.5.4 Catheter Injectability 
Injectability was examined by injecting 4oC pH 7.4 hydrogel solution into sodium 
phosphate buffers with pH of 6.5 and 7.4 at 37oC through a 26-gauge catheter (Abbot 
Voyage).  
2.5.5 Differential Scanning Calorimetry (DSC) 
The thermal properties of these hydrogel solutions at pH 6.5 and 7.4 were determined by 
differential scanning calorimetry over a temperature range from 0oC to 60oC with a 
10oC/min heating rate. The temperature at the maximum endothermal peak was used as 
the lower critical solution temperature (LCST). 
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3. Results 
3.1 Synthesis of propylacrylic acid, HEMA-PTMC, and poly (NIPAAm –co-PAA –HEMA-
PTMC) 
The structures of propylacrylic acid, HEMA-PTMC, and three copolymers were confirmed 
by 1H-NMR. The structure of PAA was confirmed by 1H-NMR by chloroform, δ: 6.23 (1H,s, 
CH2=), 5.58 (1H, s, CH2=), 2.22 (2H, t, -CH2-), 1.44 (2H, m, -CH2-) and 0.87 (3H, m, 
CH3-). The final product was a yellow oil. The spectra of PAA, HEMA-PTMC, and 
poly(NIPAAm – co – PAA – HEMA-PTMC) (Gel 1) are shown in (Fig. 5.1-5.3). The Gel 1 is 
presented as a representative. Characteristic peaks were clearly observed in the spectra, 
indicating the desired structures were obtained. The average unit ratio between TMC and 
HEMA was calculated based upon the NMR spectrum to be 2.07. The copolymer 
composition was determined by the calculation of the ratios of the characteristic peak 
integrals of NIPAAm, PAA, and HEMA-PTMC. The composition ratios of the copolymers 
were found to be different from the feed ratios (Table 2). All the characteristic peaks were 
observed in the NMR spectrum for the synthesized copolymers: HEMA-PTMC (l,q), NIPAAm 
(d), PAA (i).  
 
Table 2: Copolymer composition ratio (%) (NIPAAm/PAA/HEMA-PTMC) 
 
  
 
 
 
 
 
 
 
Hydrogel Feed Ratio Actual Ratio 
Gel 1 84/8/8 70/13/17 
Gel 2 83/12/5 71/17/12 
Gel 3 78/12/10 62/18/20 
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Figure 5.1: 1H-NMR spectrum of propylacrylic acid monomer 
 
 
Figure 5.2: 1H-NMR spectrum of HEMA-PTMC  
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Figure 5.3: 1H-NMR spectrum of poly(NIPAAm-co-PAA-HEMA-PTMC) copolymer (Gel 1) 
 
 
 
 
FTIR spectra indicates that all hydrogels possessed characteristics absorptions of NIPAAm, 
PAA, and HEMA-PTMC (Fig. 6). Gel 2 is shown as a representative. 
 
  
l, q 
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Figure 6: FT-IR spectrum of poly(NIPAAm-co-PAA-HEMA-PTMC) copolymer (Gel 2) 
 
 
3.2 Hydrogel Characterization 
All hydrogels demonstrated progressive degradation during the eight week period. Gels  2 
and 3 retained above 50% of their weight by week 4, but Gel 1 demonstrated 
comparatively rapid content loss (Fig. 7). 
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Figure 7: Hydrogel biodegradation at 37oC incubation (% content remaining) 
 
Gels 1 and 3 demonstrated they are flexible and can be stretched at 37oC under aqueous 
conditions. Gel 2, however, was too fragile and failed to demonstrate any degree of 
stretching (Fig. 8). 
  
Figure 8: Gel 1 is flexible at 37oC and can be stretched (left) before stretching, (right) after 
stretching. Gel 3 demonstrated similar properties.  
 
The mechanical properties of the hydrogel were tested using an Instron tensile tester for 
elastic modulus (Table 3). The initial linear region in the stress-strain curve was used to 
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calculate the hydrogel elastic modulus in Gels 1 and 3 via a Matlab program. Gels 1 and 3 
displayed over 300% overall strain capacity. Gel 2 was too fragile to undergo the tensile 
test. 
 
Table 3: Hydrogel elastic modulus at 37oC via tensile test 
 
 
 
 
3.3 Hydrogel Solution Characterization 
As gelation is pH dependent, it was found that all gels could be readily injected through the 
catheter. Upon injection into the warm phosphate buffers, Gel 1 exhibited gelation in both 
pH 7.4 and 6.5 buffer. Gel 2 showed gelation pH 7.4 buffer, but also indicated gelation pH 
6.5 buffer. Gel 3 retained its solution state in pH 7.4 sodium phosphate buffer, but showed 
gelation in 6.5. Injectability and gelation results for Gel 3 are displayed in Fig. 9.1 and 9.2. 
LCST of the hydrogel solutions were measured by DSC and are reported in Table 4. Only 
gel 1 did not achieve 37oC in the pH 7.4 conditions. Gel 2, however, exhibited an LCST 
greater than 37oC in acidic conditions. The relation of LCST and PAA is observed. The LCST 
of both environments increased with PAA composition.  
     
     
Hydrogel Elastic Modulus (kPa) 
Gel 1 64.60 ± 25.84 
Gel 3 219.62 ± 63.45 
Figure 9.1: Adjusted pH 7.4 Gel 3 at 4oC 
injected into buffer pH 7.4 (left) and pH 
6.5 (right) at 37oC 
Figure 9.2: All gels were injectable 
through a 26-gauge catheter 
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Table 4: Hydrogel solution characterization 
 
  
Hydrogel Injectability LCST (pH 6.5) LCST (pH 7.4) 
Gel 1 + 30.52oC 35.56oC 
Gel 2 + 40.57oC 45.00oC 
Gel 3 + 31.97oC 38.91oC 
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4. Discussion 
A pH- and thermoresponsive injectable hydrogels has been proposed as an alternative to 
circumvent the issues of premature gelation during catheter-based PCI delivery. A series of 
pH- and thermoresponsive injectable hydrogels were synthesized through varying the 
molar feed ratios of PNIPAAm, PAA, and HEMA-PTMC.  
4.1 Synthesis of PAA and HEMA-PTMC monomers and poly(NIPAAm-PAA-HEMA-PTMC) 
copolymers 
As has been widely established, the temperature, NIPAAm’s temperature sensitivity 
derives from hydrophilic and hydrophobic interactions with water in the isopropyl groups. 
Consequently, propylacrylic acid was integrated into the synthesis of the copolymers to 
introduce pH sensitivity to these thermosensitive hydrogels through capitalizing on similar 
hydrophilic and hydrophobic interactions. The results showed Gels 1 and 3 had LCSTs 
lower than 37oC at pH 6.5 and could still be injected through a catheter. While all three gels 
displayed varying degrees of gelation at pH 6.5 in 37oC aqueous environment after catheter 
injection, characteristic of ischemic conditions, gelation behavior of Gels 1 and 2 are 
inconsistent with the pH-sensitivity by also exhibiting gelation in pH 7.4 conditions.  This 
indicates Gel 3 alone possesses ideal LCSTs for catheter-based delivery. HEMA-PTMC was 
introduced to alter the mechanical properties of the hydrogel, and the introduction of 
HEMA-PTMC increases the hydrophobic interactions leading to a lower LCST. Gels 1 and 3 
had greater relative HEMA-PTMC content and possessed comparatively lower LCSTs. The 
biodegradability of the polymers suggests the greater PAA concentration in the copolymer 
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increases the hydrophilicity of the polymer as indicated by the lower content remaining in 
Gel 3 relative to gels 1 and 2.  
4.2 Mechanical Properties of Copolymer Hydrogels 
The mechanical properties of hydrogels were observed to be dependent on copolymer 
composition. The absence of elastic modulus and stretching data for Gel 2 attributed to its 
brittleness brings into question the opportunity for cross-linking during the polymerization 
process. This could account for the outstanding behavior of Gel 2 in comparison with that 
of Gels 1 and 3.  Simultaneously, the elastic modulus and stretchability for Gels 1 and 3 
indicate a greater HEMA-PTMC concentration within the hydrogel (Table 2) may increase 
the elastic properties of the polymer. This is supported by the greater elastic modulus of 
Gel 3 than that of Gel 1. In conjunction with the injectability results, it appears the greater 
hydrophobicity of the hydrogel coincides with greater elastic modulus by way of increased 
PAA and HEMA-PTMC. 
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5. Conclusions 
A series of pH- and thermo-sensitive poly(NIPAAm-co-PAA-co-HEMA-PTMC) hydrogels 
(Gels 1, 2, and 3) were synthesized by free radical polymerization. All three gels displayed 
injectability through a catheter at 37oC, and Gel 3, feed ratio 78/12/10, showed promising 
LCSTs in both pH 6.5 and 7.4 environments. Gel 3 showed optimal mechanical properties 
and degradation behavior over an 8-week period. It may be concluded that Gel 3 may 
provide a potential cell delivery vehicle for stem cell therapy. 
 
Future Work: 
There are inconsistencies in the data that would not be able to substantiate many 
conclusions in the absence of determining the polymer’s molecular weight. In this regard, 
all three hydrogels will be submitted for gel permeation chromatographic analysis to 
determine hydrogel molecular weight and polydispersity index. The calculated 
composition ratios may also suggest an alternative copolymer synthesis mechanism such 
as reversible addition-fragmentation chain-transfer polymerization may offer resolution to 
this situation [13].  
CDC encapsulation in the hydrogels to quantify cell survivability would evidence the 
viability of these hydrogels as a stem cell therapy vehicle, and to observe which of the gels 
and their respective properties would confer the fitting composition for this objective. This 
biocompatibility analysis would provide insight into the biological capacities of the 
hydrogel copolymers. 
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Finally, a degradation series should be examined in respective pH 6.5 and 7.4 as would be 
representative of the cardiac microenvironments.  
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